 Amryt Pharma PLC has announced its support for Global Epidermolysis Bullosa EB Awareness Week, which is taking place October 25 - 31, 2021. Joe Wiley, Amryts chief executive, said: Epidermolysis Bullosa is a very distressing condition which severely impacts the lives of those living with EB and also has a profound impact on parents, families and all those involved in their care. 